ArticleCancers2022

Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities.

Anjan Motamarry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.